June 15, 2017

Why REV.1 Engineering is a Top Choice for Your Medical Device Development

We’re so confident and ready to roll, that when you say “yes,” we begin working on your innovative medical device that very day. While REV•1 always creates a plan to take your medical through commercialization, your contract only needs to go to product feasibility, limiting your up-front risks and flushing out design and clinical risks early. In one phone call, you will immediately access REV•1 ’s expert R&D team: • REV•1 is owner operated and […]
June 11, 2017
Funding for medical device development

REV.1 Engineering and Your Medical Device Funding Plan

REV•1 Engineering’s medical device development typically gets clients to CE and FDA approvals before it is necessary to build a commercialization team. Most of our successful clients have not needed to hire full-time employees, other than C-level, prior to series C funding. This creates a very fast and capital-efficient model to get to a potential acquisition or confident funding of commercialization. REV•1 also understands that there are many “customers” in the commercialization chain. From health […]
June 6, 2017

Your Medical Device Development … 2x Faster

Are you hunting for an outsourced medical device R&D firm? Concerned that you won’t find a company that’s as dedicated to your project as you are? Look no further. REV•1 Engineering is owner operated and driven to succeed for you from the top down! Our clients say again and again that REV•1 takes on their project as if it were our own. That’s because our dedicated, hand-picked engineering and technical staff are devoted to making […]
May 11, 2017
FEA Graphic

Medical Device Design Case Study: Unique FEA Modeling Techniques Support R&D

We recently assisted a Southern California biotechnology company that is developing a novel immunotherapy for treating cancer. Immunotherapy is an exciting emerging field and we were happy to be involved in this potential game-changing technology. This client had strong intellectual property and a strong team of scientists with deep experience and expertise. They came to us with a need to deliver a biologic payload to a target in tissue – and to combine the payload […]